Iontocaine

   
Google
 
Web NewDrugInformation.com

Iontocaine


Drug - Iontocaine
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; IONTOPHORESIS
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Epinephrine; Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.01MG/ML;2%
The potency of the active ingredient(s), Epinephrine; Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - IOMED
The firm name holding legal responsibility for Iontocaine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020530
The FDA assigned number to Iontocaine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Iontocaine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 21, 1995
The date Iontocaine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Iontocaine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Iontocaine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Iomed Inc
The full name of the firm holding legal responsibility for the new application of Iontocaine.

Iontocaine